In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 3, 2013, Pages 523-528

  Furustrand Tafin, Ulrika ^a   Trampuz, Andrej ^a   Corvec, Stéphane ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Biofilm; Combinations; Implant related infections

Indexed keywords

CLINDAMYCIN; DAPTOMYCIN; LEVOFLOXACIN; PENICILLIN G; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; IN VITRO STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROPIONIBACTERIUM ACNES; SEQUENCE ALIGNMENT;

ANTI-BACTERIAL AGENTS; DNA MUTATIONAL ANALYSIS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROPIONIBACTERIUM ACNES; RIFAMPIN; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE;

EID: 84873603864     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks428     Document Type: Article

References (26)

1. Achermann Y, Vogt M, Leunig M et al. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol 2010; 48: 1208-14.
2. Piper KE, Jacobson MJ, Cofield RH et al. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol 2009; 47: 1878-84.
3. Butler-Wu SM, Burns EM, Pottinger PS et al. Optimization of periprosthetic culture for the diagnosis of Propionibacterium acnes prosthetic joint infection. J Clin Microbiol 2011; 49: 2490-5.
4. Hoeffler U, Ko HL, Pulverer G. Antimicrobial susceptibility of Propionibacterium acnes and related microbial species. Antimicrob Agents Chemother 1976; 10: 387-94.
5. Bayston R, Nuradeen B, AshrafWet al. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection. J Antimicrob Chemother 2007; 60: 1298-301.
6. Furustrand Tafin U, Corvec S, Betrisey B et al. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2012; 56: 1885-91.
7. Campbell EA, Korzheva N, Mustaev A et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001; 104: 901-12.
8. Adekambi T, Drancourt M, Raoult D. The rpoB gene as a tool for clinical microbiologists. Trends Microbiol 2009; 17: 37-45.
9. Aubry-Damon H, Soussy CJ, Courvalin P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 2590-4.
10. Jin DJ, Gross CA. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 1988; 202: 45-58.
11. Aubry-Damon H, Galimand M, Gerbaud G et al. rpoB mutation conferring rifampin resistance in Streptococcus pyogenes. Antimicrob Agents Chemother 2002; 46: 1571-3.
12. Telenti A, Imboden P, Marchesi F et al. Detection of rifampicinresistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-50.
13. Tupin A, Gualtieri M, Roquet-Baneres F et al. Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns. Int J Antimicrob Agents 2010; 35: 519-23.
14. Pannu J, McCarthy A, Martin A et al. In vitro antibacterial activity of NB-003 against Propionibacterium acnes. Antimicrob Agents Chemother 2011; 55: 4211-7.
15. Clinical Laboratory Standards Institute. Methods for Susceptibility Testing of Anaerobic Bacteria-Seventh Edition: Approved Standard M11-A7. CLSI, Wayne, PA, USA, 2007.
16. Cottagnoud P, Entenza JM, Cottagnoud M et al. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiol 2001; 1: 9.
17. Entenza JM, Giddey M, Vouillamoz J et al. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. Int J Antimicrob Agents 2010; 35: 451-6.
18. Wichelhaus TA, Schafer V, Brade V et al. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 2813-6.
19. Bruggemann H, Henne A, Hoster F et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004; 305: 671-3.
20. Blattner FR, Plunkett G III, Bloch CA et al. The complete genome sequence of Escherichia coli K-12. Science 1997; 277: 1453-62.
21. Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994; 38: 805-11.
22. Aboshkiwa M, Rowland G, Coleman G. Nucleotide sequence of the Staphylococcus aureus RNA polymerase rpoB gene and comparison of its predicted amino acid sequence with those of other bacteria. Biochim Biophys Acta 1995; 1262: 73-8.
23. Aboshkiwa M, al-Ani B, Coleman G et al. Cloning and physical mapping of the Staphylococcus aureus rplL, rpoB and rpoC genes, encoding ribosomal protein L7/L12 and RNA polymerase subunits β and β′. J Gen Microbiol 1992; 138: 1875-80.
24. Guo B, Abdelraouf K, Ledesma KR et al. Predicting bacterial fitness cost associated with drug resistance. J Antimicrob Chemother 2012; 67: 928-32.
25. Baquero MR, Nilsson AI, Turrientes Mdel C et al. Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. J Bacteriol 2004; 186: 5538-42.
26. John AK, Baldoni D, Haschke M et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009; 53: 2719-24.